Skip to content
Film Television Auditions – Lifestyle
Author:
PolarityBio
Dr. Robert Langer, Co-Founder of Moderna, Joins PolarityBio’s Board of Directors
November 16, 2026
PolarityBio Highlights Highest Scoring Abstract Award and Presentation of Phase 3 COVER DFUS II Trial Results at SAWC Fall 2026
October 20, 2026
PolarityBio’s Phase 3 COVER DFUS II Trial Selected for First-to-Podium Presentation at SAWC Fall 2026
September 29, 2026
PolarityBio Announces FDA Acceptance for Filing of SkinTE® BLA with Priority Review in Diabetic Foot Ulcers
September 15, 2026
PolarityBio Announces Submission of its Biologics License Application for SkinTE® for the Treatment of Wagner Grade 1 Diabetic Foot Ulcers
July 1, 2026